HI
BEAT

HBK Investments’s BioTelemetry, Inc. BEAT Stock Holding History

HBK Investments’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,794
Closed -$346K – 1507
2018
Q4 		$346K Buy
+5,794
New +$348K ﹤0.01% 999
2017
Q4 		– Sell
-7,100
Closed -$234K – 1239
2017
Q3 		$234K Buy
+7,100
New +$246K ﹤0.01% 932

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HBK Investments's BEAT Position: Q1 2019 in Review

HBK Investments sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 5,794 shares — an estimated $346K sold.

HBK Investments first reported a position in BEAT in Q3 2017 and held it in 2 quarters. The position peaked at $346K in Q4 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

  • HBK Investments reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
  • HBK Investments sold 5,794 BioTelemetry, Inc. shares in Q1 2019, an estimated $346K.
  • HBK Investments first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 2 quarters.
  • HBK Investments's BioTelemetry, Inc. position peaked at $346K in Q4 2018.
  • 311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.